CD19 and lupus nephritis: A 20-year-old woman with severe SLE resistant to numerous therapies with active lupus nephritis, nephrotic syndrome, pericarditis, pleuritis, rash, arthritis was treated with CD19-targeted CAR-T cell therapy.